ZA874597B - The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs - Google Patents

The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs

Info

Publication number
ZA874597B
ZA874597B ZA874597A ZA874597A ZA874597B ZA 874597 B ZA874597 B ZA 874597B ZA 874597 A ZA874597 A ZA 874597A ZA 874597 A ZA874597 A ZA 874597A ZA 874597 B ZA874597 B ZA 874597B
Authority
ZA
South Africa
Prior art keywords
factor against
protective factor
against toxicity
tumoral diseases
gangliosides
Prior art date
Application number
ZA874597A
Other languages
English (en)
Inventor
Valle Francesco Della
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ZA874597B publication Critical patent/ZA874597B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA874597A 1986-06-30 1987-06-25 The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs ZA874597B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8648203A IT1208751B (it) 1986-06-30 1986-06-30 Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali

Publications (1)

Publication Number Publication Date
ZA874597B true ZA874597B (en) 1988-03-30

Family

ID=11265194

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874597A ZA874597B (en) 1986-06-30 1987-06-25 The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs

Country Status (16)

Country Link
US (1) US5229373A (xx)
EP (1) EP0251298B1 (xx)
JP (1) JPS6327434A (xx)
AT (1) ATE69381T1 (xx)
AU (1) AU601988B2 (xx)
BE (1) BE1000723A4 (xx)
CA (1) CA1314219C (xx)
DE (2) DE3721562A1 (xx)
DK (1) DK165621C (xx)
ES (1) ES2038621T3 (xx)
FR (1) FR2601248B1 (xx)
GR (2) GR871005B (xx)
IL (1) IL82944A (xx)
IT (1) IT1208751B (xx)
LU (1) LU86930A1 (xx)
ZA (1) ZA874597B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254280B (it) * 1992-03-13 1995-09-14 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
US6765087B1 (en) * 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
DE4430041A1 (de) † 1994-08-24 1996-02-29 Milupa Ag Allergieprotektive Formelnahrung
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
EP1603932B1 (en) 2003-03-06 2012-10-03 Seneb Biosciences Inc. Methods and compositions for the enzymatic synthesis of gangliosides
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali

Also Published As

Publication number Publication date
JPS6327434A (ja) 1988-02-05
DK333787D0 (da) 1987-06-29
IT1208751B (it) 1989-07-10
GR3003790T3 (xx) 1993-03-16
LU86930A1 (fr) 1987-11-11
DK333787A (da) 1987-12-31
BE1000723A4 (fr) 1989-03-21
IL82944A (en) 1993-04-04
FR2601248A1 (fr) 1988-01-15
GR871005B (en) 1987-10-23
EP0251298A3 (en) 1988-10-26
EP0251298A2 (en) 1988-01-07
AU7490887A (en) 1988-01-07
AU601988B2 (en) 1990-09-27
FR2601248B1 (fr) 1989-08-25
DK165621C (da) 1993-06-01
ATE69381T1 (de) 1991-11-15
DE3721562A1 (de) 1988-03-03
DE3774501D1 (de) 1991-12-19
DK165621B (da) 1992-12-28
EP0251298B1 (en) 1991-11-13
ES2038621T3 (es) 1993-08-01
CA1314219C (en) 1993-03-09
US5229373A (en) 1993-07-20
IT8648203A0 (it) 1986-06-30

Similar Documents

Publication Publication Date Title
PH24313A (en) Emulsion composition for administration of sparingly water soluble ionizable hydrophobic drugs
ES8104720A1 (es) Un procedimiento para la preparacion de composiciones lipo- somicas de substancias activas grasosolubles
EP0254067A3 (en) Composition for metastasis prevention
FR2651677B1 (fr) Composition pharmaceutique a base de salmeterol et du propionate de fluticasone.
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ZA874597B (en) The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs
DE69033183D1 (de) Phosphozucker enthaltende pharmazeutische zubereitung
ATE58837T1 (de) Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebschemotherapie und erhoehung der immunitaet.
ITMI920591A1 (it) Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
IT1236584B (it) Uso di gangliosidi nel trattamento della disfunzione autonomica nel morbo di chagas
DE69427966T2 (de) Neue o-sulfatierte ganglioside und lyso-ganglioside-derivaten
MY111155A (en) Medicaments